THE USE OF PACLITAXEL IN CHEMORADIOTHERAPY OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL: A PILOT STUDY

THE USE OF PACLITAXEL IN CHEMORADIOTHERAPY OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL: A PILOT STUDY

Objectives: to assess the feasibility of a combination of the intensity-modulated radiation therapy (IMRT) with a triplet chemotherapy with paclitaxel, capecitabine, and mitomycin C in the treatment of patients with anal cancer, and to evaluate the toxicity of the proposed treatment regimen.Material...

Full description

Bibliographic Details
Main Authors: S. S. Gordeev, V. A. Gorbunova, S. I. Tkachev, V. V. Glebovskaya, N. S. Besova, Yu. E. Suraeva, M. Yu. Fedyanin, V. A. Ivanov, V. S. Anan’ev, A. G. Malikhov, A. O. Rasulov
Format: Article
Language:Russian
Published: “ABV-press” Publishing house”, LLC 2017-01-01
Series:Тазовая хирургия и онкология
Subjects:
anal carcinoma
squamous-cell cancer
chemoradiotherapy
paclitaxel
Online Access:https://ok.abvpress.ru/jour/article/view/187

Internet

https://ok.abvpress.ru/jour/article/view/187

Similar Items